Cyclic amides (including cyclic carbamates) and their derivatives: ethinamate and its salts

In 2024, cyclic amides (including cyclic carbamates) and their derivatives: ethinamate and its salts trade exhibited strong growth, with global flows reaching $214,766 and a three-year compound annual growth rate of +18.5% (five-year: -12.7%). The all-time peak of $4,200,012 was recorded in 2002; the current level is 95% below that high-water mark.

Over the 30-year observation window (1995–2024), 41% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is strengthening (+33.7% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.361). The three largest exporters — France ($945.6K), United States ($721.7K), and Netherlands ($553.6K) — collectively dominate supply flows. The leading exporter has grown at -98.5% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.475). The three largest import markets are Egypt ($135.5K), Netherlands ($124.6K), and Israel ($55.0K). The largest importing market sources from 2 different supplying countries.

The dominant trade corridor is France → Ireland at $809.6K, representing 65.9% of the importer's total demand.

The volatility score for cyclic amides (including cyclic carbamates) and their derivatives: ethinamate and its salts is 50 out of 100, classified as medium. Trade flows are moderately variable, typical for goods with seasonal or cyclical demand patterns.

For market entrants, strong demand tailwinds create a favourable entry environment. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "Medium" based on reporting coverage and consistency across OECD member and partner countries.